Using simulation to estimate the cost effectiveness of improving ambulance and thrombolysis response times after myocardial infarction

Objectives: To quantify the health gains and costs associated with improving ambulance and thrombolysis response times for acute myocardial infarction. Design: A computer simulation model. Patients/setting: Patients experiencing acute myocardial infarction in England. Interventions: Improving the ambulance response time to 75% of calls reached within 8 minutes and the hospital arrival to thrombolysis time interval (door-to-needle time) to 75% receiving it within 30 minutes and 20 minutes, compared to best estimates of response times in the mid-1990s. Main outcome measures: Deaths prevented, life years saved, and discounted cost per life year saved. Results: Improving the ambulance response to 75% of calls within 8 minutes resulted in an estimate of 5 deaths prevented or 57 life years saved per million population per year, with a discounted incremental cost per life year saved of £8540 over 20 years. The corresponding benefit of improving the door-to-needle time to 75% of myocardial infarction patients within 30 minutes was an estimated 2 deaths prevented and 15 life years saved per million population per year, with a discounted incremental cost per life year saved of between £10 150 to £54 230 over 20 years. Little further gain was associated with reaching the 20 minute target. Combining ambulance and thrombolysis targets resulted in 70 life years saved per million population per year. Conclusions: Improving ambulance response times appears to be cost effective. Reducing door-to-needle time will have a smaller effect at an uncertain cost. Further benefits may be gained from reducing the time from onset of symptoms to starting thrombolysis.

[1]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[2]  T. Allan,et al.  Impact of a Region-Wide Approach to Improving Systems for Heart Attack Care: The West Midlands Thrombolysis Project , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[3]  M. Redmond,et al.  "Heartstart Scotland"--initial experience of a national scheme for out of hospital defibrillation. , 1991, BMJ.

[4]  D. O'Gorman,et al.  Safety and efficacy of nurse initiated thrombolysis in patients with acute myocardial infarction , 2002, BMJ : British Medical Journal.

[5]  Ruth Davies,et al.  Simulating health systems: modelling problems and software solutions , 1995 .

[6]  C. Fry,et al.  Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.

[7]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[8]  R. Collins,et al.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither , 1998, BMJ.

[9]  R. Lloyd‐Mostyn.  National service framework for coronary heart disease , 2000, BMJ : British Medical Journal.

[10]  J. Pell,et al.  Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study , 2001, BMJ : British Medical Journal.

[11]  Fibrinolytic Therapy Trialists' Collaborative Group.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994, The Lancet.

[12]  J Raftery,et al.  NICE: faster access to modern treatments? Analysis of guidance on health technologies , 2001, BMJ : British Medical Journal.

[13]  J. Pell,et al.  Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period , 2001, Heart.

[14]  Ruth Davies,et al.  The Development of a Simulation Model of the Treatment of Coronary Heart Disease , 2002, Health care management science.

[15]  Eric Boersma,et al.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.

[16]  W. Daniel,et al.  Role of transoesophageal echocardiography in infective endocarditis , 2000, Heart.

[17]  Bhash Naidoo,et al.  The Development of a Simulation Model of Primary Prevention Strategies for Coronary Heart Disease , 2002, Health care management science.

[18]  G. Eslick.  Chest pain units. , 2008, Disease-a-month : DM.

[19]  T. Quinn,et al.  Improving door to needle times with nurse initiated thrombolysis , 2000, Heart.

[20]  A. Crook,et al.  Hypothetical ratings of coronary angiography appropriateness: are they associated with actual angiographic findings, mortality, and revascularisation rate? The ACRE study , 2001, Heart.

[21]  R. Norris.  A new performance indicator for acute myocardial infarction , 2001, Heart.

[22]  J. Birkhead.  Thrombolytic treatment for myocardial infarction: an examination of practice in 39 United Kingdom hospitals. Myocardial Infarction Audit Group. , 1997, Heart.

[23]  S. Pocock,et al.  Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery , 1995, The Lancet.

[24]  R. Luepker,et al.  An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital. , 1996, Heart.